Results from plasmaMATCH trial treatment cohort D: A phase II trial of capivasertib in patients with an AKT activation basket mutation identified via ctDNA testing or tumour sequencing (CRUK/15/010)
Published in 2020 by
Richard D. Baird,
Lucy Kilburn 
,
Sarah Kernaghan,
Andrew M. Wardley,
Iain Macpherson,
Rebecca Roylance,
Peter Stephens,
Olga Oikonomidou,
Jeremy P. Braybrooke,
Mark Tuthill,
Jacinta Abraham,
Matthew C. Winter,
Belinda Kingston,
Katie Wilkinson,
Nicholas Turner
and other authors.
,
Sarah Kernaghan,
Andrew M. Wardley,
Iain Macpherson,
Rebecca Roylance,
Peter Stephens,
Olga Oikonomidou,
Jeremy P. Braybrooke,
Mark Tuthill,
Jacinta Abraham,
Matthew C. Winter,
Belinda Kingston,
Katie Wilkinson,
Nicholas Turner
and other authors.
